-
FROM POLICY TO PRACTICE: ASSESSING THE AI GOVERNANCE IMPLEMENTATION GAP ACROSS HEALTH TECHNOLOGY ASSESSMENT AGENCIES: A CROSS-NATIONAL READINESS REVIEW
Aug 11, 2026, 17:15 PM -
ECONOMIC OUTCOMES OF EMICIZUMAB IN MANAGING HAEMOPHILIA A AMONG CHILDREN AND ADULTS IN THE UAE: MONETIZATION OF A RETROSPECTIVE ANALYSIS CONDUCTED AT TAWAM HOSPITAL AND SHEIKH KHALIFA MEDICAL CITY
Aug 11, 2026, 17:15 PM -
SIMULATING TREATMENT ESCALATION IN TYPE 2 DIABETES DISEASE STATE MODELING: AN APPLICATION TO COST-EFFECTIVENESS ANALYSIS OF TUBELESS AUTOMATED INSULIN DELIVERY
Aug 11, 2026, 17:15 PM -
COST-EFFECTIVENESS ANALYSIS OF SINGLE-INHALER EXTRAFINE BECLOMETHASONE/FORMOTEROL/GLYCOPYRRONIUM BROMIDE FOR ADULT PATIENTS WITH UNCONTROLLED ASTHMA FROM THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE
Aug 11, 2026, 17:15 PM -
LONGITUDINAL ANALYSIS OF EOSINOPHILIC ESOPHAGITIS IN CLAIMS DATA BEFORE THE INTRODUCTION OF A SPECIFIC ICD-10-GM-CODE
Aug 11, 2026, 17:15 PM -
ADHERENCE TO THE ISPOR GLOBAL PHARMACOECONOMIC MODEL ADAPTATION GUIDANCE: A REVIEW OF PUBLISHED ECONOMIC MODEL ADAPTATIONS
Aug 11, 2026, 17:15 PM -
A MULTI-SEASON, REPEATED CROSS-SECTIONAL SURVEY STUDY ON MATERNAL AWARENESS, IMMUNIZATION PREFERENCES AND UPTAKE DRIVERS FOR RSV PROTECTION IN INFANTS IN GERMANY (2022-2026)
Aug 11, 2026, 17:15 PM -
TRIMESTER-SPECIFIC MATERNAL ERYTHROCYTE INDICES AS PREDICTORS OF ADVERSE NEONATAL OUTCOMES: A CROSS-SECTIONAL STUDYFROMA HIGH-BURDEN LMIC SETTING
Aug 11, 2026, 17:15 PM -
CHANGES IN THE NUMBER OF PREGNANCY AND LACTATION POST-MARKETING REQUIREMENTS/COMMITMENTS ISSUED BY THE FDA AFTER THE RELEASE OF THE DRAFT POSTAPPROVAL PREGNANCY SAFETY STUDIES GUIDELINES IN 2019
Aug 11, 2026, 17:15 PM -
VALIDATING GENERATIVE AI-ASSISTED SYSTEMATIC LITERATURE REVIEW WORKFLOWS IN HEOR: ACCURACY, EFFICIENCY, AND GOVERNANCE IMPLICATIONS
Aug 11, 2026, 17:15 PM -
SYSTEMATIC EVALUATION OF CLINICAL DATA MODEL COVERAGE AND ALIGNMENT WITH ESMO PRECISION ONCOLOGY MOLECULAR TUMOUR BOARD RECOMMENDATIONS
Aug 11, 2026, 17:15 PM -
BUDGET IMPACT OF SUBCUTANEOUS IMMUNOGLOBULIN 20% (IGPRO20) IN CIDP FROM A GERMAN STATUTORY HEALTH INSURANCE PERSPECTIVE
Aug 11, 2026, 17:15 PM -
ECONOMIC VALUE OF PHARMACY AUTOMATION IN HOSPITALS: AN UPDATED SYSTEMATIC REVIEW
Aug 11, 2026, 17:15 PM -
EVALUATION OF COST-EFFECTIVENESS MODELS FOR LIPID-LOWERING THERAPIES IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PREVENTION: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:15 PM -
COMPARATOR SELECTION IN JAPAN'S HTA SYSTEM: FROM GUIDELINE PRINCIPLES TO PRACTICE, AND COMPARISON WITH INTERNATIONAL HTA AGENCIES
Aug 11, 2026, 17:15 PM -
EVALUATING THE TRANSPORTABILITY OF NON-INFERIORITY EVIDENCE FOR CHEMOTHERAPHY DE-ESCALATION IN N+ HR+HER2- BREAST CANCER: A HTA SIMULATION STUDY
Aug 11, 2026, 17:15 PM -
ACCESS TO MODERN THERAPIES FOR PROSTATE CANCER PATIENTS IN CENTRAL AND EASTERN EUROPE (CEE): A CROSS-COUNTRY ASSESSMENT OF HTA AND REIMBURSEMENT PATHWAYS
Aug 11, 2026, 17:15 PM -
ESTIMATING REAL-WORLD HEALTHCARE COSTS ATTRIBUTABLE TO ADVERSE EVENTS IN PATIENTS WITH METASTATIC BREAST CANCER OR ACUTE MYELOID LEUKEMIA IN TAIWAN
Aug 11, 2026, 17:15 PM -
EXPONENTIAL GROWTH AND MARKET CONCENTRATION OF PUBLIC REIMBURSEMENT FOR INNOVATIVE CARDIOMETABOLIC PHARMACOTHERAPY IN HUNGARY, 2020-2025
Aug 11, 2026, 17:15 PM -
EXPLORING ADMINISTRATIVE BURDEN AND BURNOUT AMONG ITALIAN ONCOLOGISTS: A CROSS-SECTIONAL SURVEY
Aug 11, 2026, 17:15 PM
